Head, US PA&PA Immunology

Job Title: Head, US PA&PA Immunology

• Location: Cambridge, MA / Washington, DC / Morristown, NJ

About the Job:

Head, US Public Affairs & Patient Advocacy, Immunology

Reports to:

VP & Head, US Public Affairs & Patient Advocacy | Member: US PA&PA Leadership Team;
Extended Leadership Teams of the US Immunology Business Unit;
Alliance PA&PA Governance

Location:

Hybrid | Travel: up to 25%, primarily domestic

Sanofi believes the US healthcare system should understand and solve for what matters most to patients. We are committed to working with patient advocacy organizations to accelerate research and development of medicines that address unmet needs, and to developing solutions that overcome barriers so people have affordable and sustainable access to the right treatments.

US PA&PA Immunology exists to close the gap between when disease begins and when patients receive appropriate, timely care. The function operates an outcome-driven advocacy model: a prioritized portfolio of priorities, measured against defined patient outcome goals. The Head leads this model and shapes its continued evolution. Sanofi’s immunology portfolio is anchored by Dupixent and an immunology pipeline spanning dermatology, respiratory, rhinology, gastrointestinal disease, and Type 2 inflammation.

The Head, US PA&PA Immunology carries deep therapeutic area leadership combined with enterprise-level contribution:

• Therapeutic area leadership: owns the US advocacy strategy and outcomes for the full Immunology portfolio, Dupixent across dermatology, respiratory, rhinology, gastrointestinal and Type 2 inflammation indications, plus Sanofi’s non-alliance immunology assets and pipeline. Leads and develops a team of US PA&PA leads. Accountable for budget and patient outcomes.
• Enterprise leadership:
  Ensures alignment of patient advocacy and public affairs strategies with Corporate Affairs goals and colleagues. Serves as a full member of the US PA&PA Leadership Team, co-owning functional strategy, talent, and the continued development of the function’s capabilities and ways of working, and contributing enterprise judgment on the patient-access environment and corporate reputation beyond therapeutic area boundaries

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

About Sanofi:

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

Main Responsibilities

Outcomes-Driven Strategic Leadership

• Set and own the creation and execution of the US PA&PA Immunology strategy as a prioritized portfolio of priorities, each with explicit patient outcome measures.
• Set the US PA&PA strategy for immunology, partner relationships, and patient-community understanding years before new treatment options may reach patients-
• Use data, evidence, and the function’s decision-support platforms to connect strategy, partnerships, programs, and outcomes.
• Manage and be accountable for securing the US PA&PA budgets across dermatology, respiratory, rhinology, gastrointestinal, allergy, and pipeline immunology, ensuring disciplined planning, allocation, and full accountability for how advocacy resources are deployed.

External Partnership & Thought Leadership

• Accountable for Sanofi’s trusted partnerships with the US advocacy community across the immunology therapeutic area, owning the health, depth, and outcomes of relationships with patient advocacy organizations and professional societies, and earning continued partnership through transparency, consistency, and the quality of collaboration in service of shared patient priorities.
• Bring senior fluency in the US patient access environment and translate its implications for patients into the function’s advocacy strategy and priorities.
• Stay…